Ikena Oncology Financial Activities - Other 2021-2025 | IMA
Ikena Oncology financial activities - other from 2021 to 2025. Financial activities - other can be defined as the net amount of items a company reports that are too small to report separately. Additionally, this field holds the sum of items a company reports that cannot be assigned to any other standardized field in the financing activities section of the Cash Flows Statement.
Ikena Oncology Annual Financial Activities - Other
(Millions of US $) |
| 2024 |
$N/A |
| 2023 |
$39 |
| 2022 |
$N/A |
| 2021 |
$N/A |
| 2020 |
$N/A |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.061B |
$0.009B |
|
Ikena Oncology Inc. is focused on developing cancer therapies targeting key signaling pathways which drive the formation and spread of cancer. The company's product candidates include IK-930, IK-175, IK-412 and IK-007, which are in clinical stage. Ikena Oncology Inc. is based in Boston, United States.
|
